A range of editorial illustrations completed for the New York Times, Bloomberg Businessweek, Highsnobiety, Spike Art Magazine, The Intercept, The Baffler, and (?) a few more (???). Displayed in a vaguely chronological order. At times art directors have an idea in mind, but 99% of the time I have pitched and developed the concepts that the AD then shops to their editor, which we then develop together.
Word Through The Times: Gridlock
Type illustration for the word 'Gridlock' referencing the NYC municipal parking signs as a formal endorsement of bad traffic patterns. AD Vinnie Neuberg
The Counterpublic Option
Cover for The Baffler concerning dynamics of speech & amplification of marginalized voices. The idea here was call-and-response vocalization informed by Occupy Wallstreet's use of the Human Microphone. This dynamic plays out from rear cover onto the front, creating a two-panel comic of sorts. The Baffler was kind enough to let me blobify their logo in the process. Completed with AD No Ideas Studio cc Devin Washburn and Philip DiBello.
2020 Was Good, For Some
For an article concerning middle-class insulation amid the economic devastation caused by Covid-19 (and the US governments death-cult attitude.) Completed with AD Michael Houtz.
Highsnobiety Quarterly Insights
For Highsnobiety's quarterly fashion-industry updates. Each iteration features currency symbols getting into themed hijinx. From initial pandemic anxiety, to a hot hot summer, to fitness, to new years celebration. Each quarter includes updated character PNG sheets and animations. Completed with AD Manus Browne and Editor-in-Chief Thom Bettridge.
Streetwear Has A Sustainability Problem
For Highsnobiety. Completed with AD Manus Browne and Editor-in-Chief Thom Bettridge.
A series of illustrations explaining Gen-Z's market trends to Millenials and Boomers. for Bloomberg/Bloomberg Businessweek, AD(s): Steph Davidson and Chris Nosenzo
Dark Arts: Notes on Fashion, Content, and Magic
For Spike Art Magazine regarding consolidation of power in fashion houses, Writer/AD: Thom Bettridge
How Pharma Lost Its Edge in Washington
for Bloomberg Businessweek, AD: Shawn Hasto